ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

A multi-center imaging trial by the American College of Radiology Imaging Network (ACRIN) “A Multicenter, phase II assessment of tumor hypoxia in glioblastoma using (18)F Fluoromisonidazole (FMISO) with PET and MRI (ACRIN 6684)”, was conducted to assess hypoxia in patients with glioblastoma (GBM). T...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Ratai, Eva-Maria, Zhang, Zheng, Fink, James, Muzi, Mark, Hanna, Lucy, Greco, Erin, Richards, Todd, Kim, Daniel, Andronesi, Ovidiu C., Mintz, Akiva, Kostakoglu, Lale, Prah, Melissa, Ellingson, Benjamin, Schmainda, Kathleen, Sorensen, Gregory, Barboriak, Daniel, Mankoff, David, Gerstner, Elizabeth R.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6002091/
https://ncbi.nlm.nih.gov/pubmed/29902200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0198548
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料